| Primary |
| Prophylaxis |
22.2% |
| Cough |
11.1% |
| Decreased Appetite |
11.1% |
| Hyperlipidaemia |
11.1% |
| Hypertension |
11.1% |
| Metastatic Renal Cell Carcinoma |
11.1% |
| Mucosal Inflammation |
11.1% |
| Renal Cancer Metastatic |
11.1% |
|
|
| Secondary |
| Metastatic Renal Cell Carcinoma |
23.4% |
| Renal Cell Carcinoma |
11.7% |
| Hypertension |
9.1% |
| Prophylaxis |
7.8% |
| Renal Cancer |
6.5% |
| Renal Cancer Metastatic |
5.2% |
| Cough |
3.9% |
| Decreased Appetite |
3.9% |
| Mucosal Inflammation |
3.9% |
| Angiosarcoma |
2.6% |
| Gastritis |
2.6% |
| Gastrointestinal Stromal Tumour |
2.6% |
| Hyperlipidaemia |
2.6% |
| Metastases To Bone |
2.6% |
| Metastases To Lung |
2.6% |
| Metastasis |
2.6% |
| Palmar-plantar Erythrodysaesthesia Syndrome |
2.6% |
| Acute Myeloblastic Leukemia |
1.3% |
| Blood Pressure |
1.3% |
| Colitis Ulcerative |
1.3% |
|
| Cardiotoxicity |
10.7% |
| Hepatitis Fulminant |
7.1% |
| Myocardial Infarction |
7.1% |
| Proteinuria |
7.1% |
| Renal Failure |
7.1% |
| Skin Ulcer |
7.1% |
| Transaminases Increased |
7.1% |
| Atrial Fibrillation |
3.6% |
| Cardiac Failure Congestive |
3.6% |
| Catheter Site Haemorrhage |
3.6% |
| Decreased Appetite |
3.6% |
| Disease Progression |
3.6% |
| Gait Disturbance |
3.6% |
| Hepatic Neoplasm Malignant |
3.6% |
| Pleural Effusion |
3.6% |
| Pyrexia |
3.6% |
| Renal Cancer Metastatic |
3.6% |
| Renal Cell Carcinoma |
3.6% |
| Thrombocytopenia |
3.6% |
| Tricuspid Valve Incompetence |
3.6% |
|
| Concomitant |
| Metastatic Renal Cell Carcinoma |
73.4% |
| Prophylaxis |
7.6% |
| Renal Cell Carcinoma |
7.5% |
| Hypertension |
1.9% |
| Metastases To Thorax |
1.9% |
| Infection Prophylaxis |
0.8% |
| Insomnia |
0.8% |
| Blood Glucose Increased |
0.7% |
| Diabetes Mellitus |
0.7% |
| Metastases To Bone |
0.7% |
| Acute Myeloid Leukaemia |
0.6% |
| Gastritis |
0.5% |
| Hyperlipidaemia |
0.5% |
| Constipation |
0.4% |
| Adrenal Insufficiency |
0.4% |
| Allergy Prophylaxis |
0.4% |
| Anaemia |
0.4% |
| Bone Marrow Conditioning Regimen |
0.4% |
| Eczema |
0.4% |
| Renal Transplant |
0.4% |
|
| Neoplasm Malignant |
15.8% |
| Stomatitis |
12.7% |
| Malignant Neoplasm Progression |
8.5% |
| C-reactive Protein Increased |
6.1% |
| Platelet Count Decreased |
5.5% |
| Pyrexia |
5.5% |
| Anaemia |
4.2% |
| Haemoglobin Decreased |
4.2% |
| Malaise |
4.2% |
| Gamma-glutamyltransferase Increased |
3.6% |
| Neoplasm Progression |
3.6% |
| Renal Impairment |
3.6% |
| Interstitial Lung Disease |
3.0% |
| Lymphocyte Count Decreased |
3.0% |
| Pleural Effusion |
3.0% |
| Sepsis |
3.0% |
| Thrombocytopenia |
3.0% |
| Blood Glucose Increased |
2.4% |
| Gastrointestinal Perforation |
2.4% |
| Myocardial Infarction |
2.4% |
|
| Interacting |
| Constipation |
25.0% |
| Haemorrhoids |
25.0% |
| Hypertension |
25.0% |
| Metastases To Lung |
25.0% |
|
|
